President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank has ignited market speculation over the future path of interest rates, with analysts divided on whether his leadership would mean more cuts or a return to hawkish restraint.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
President Trump's nomination of former Fed governor Kevin Warsh to lead the central bank has sparked immediate concerns on Wall Street about political influence over monetary policy, setting the stage for a contentious Senate confirmation battle.
Amidst a choppy market, value investors are hunting for bargains. We spotlight three companies—Dingdong, Origin Bancorp, and ATRenew—whose current share prices appear significantly disconnected from their estimated intrinsic value, presenting potential opportunities for the discerning investor.
Amid a cautiously optimistic market backdrop, companies where executives hold significant stakes are drawing investor attention. We examine three such firms where insider buying and strategic moves signal confidence in long-term growth.
Meta Platforms announces a 10% workforce reduction in its Reality Labs division, signaling a strategic shift away from its massive metaverse investments toward artificial intelligence and augmented reality, raising questions about the company's future profitability and stock performance.
As markets swing between optimism and caution, income-focused investors are turning to dividend payers for potential stability. We analyze three stocks offering yields from 3.5% to over 10%, each with a distinct risk and reward profile.
In a major shift, President Javier Milei's government has formally transferred control of liquefied natural gas imports from the state-owned Enarsa to private companies, accelerating a sweeping privatization agenda amid concerns over winter supply and future prices.
BHP Group achieves a key milestone with full autonomy at its Escondida Norte copper pit, boosting safety and efficiency for its strategic copper expansion. Meanwhile, the miner contends with the commercial impact of China's ongoing ban on iron ore from its Jimblebar operation, forcing a reshuffle of global sales channels.
Visa is aggressively expanding its footprint beyond traditional card payments, launching new initiatives in stablecoin settlements, renter-focused commerce, and streamlined crypto-to-fiat conversions. These partnerships aim to embed Visa's network into the burgeoning worlds of blockchain-based finance and essential housing expenditures.
Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.
Paramount Skydance is launching a new programmatic advertising platform for live sports on Paramount+ and initiating a quarterly dividend, signaling a strategic shift towards monetizing its existing audience amid ongoing financial pressures.
New satellite imagery shows Iran constructing roofs over bomb-damaged buildings at its Isfahan and Natanz nuclear facilities, a move analysts say is likely aimed at shielding recovery efforts from surveillance as international pressure mounts over Tehran's internal crackdown and nuclear ambitions.
The wealth management sector kicks off the year with strategic acquisitions and rebranding moves. Corient expands its Silicon Valley footprint, Carson integrates a long-time partner, and Cetera lures a team from Raymond James, highlighting the ongoing consolidation and competition for advisor talent.
As demand for AI infrastructure surges, Broadcom's custom chip business positions it for sustained growth, with analysts highlighting its potential for long-term portfolio gains despite its absence from some top stock lists.
A pivotal week in business saw Tesla's long-awaited robotaxis begin operations without safety drivers, signaling a new phase in autonomous mobility. Meanwhile, Greg Abel's early moves at Berkshire Hathaway hint at a potential strategic shift, and a push for tokenized, round-the-clock stock trading raises questions about the future of finance.
Yemen's Houthi rebels have seized telecommunications equipment and vehicles from multiple UN offices in Sana'a, the United Nations reported Friday, marking a significant escalation in restrictions that threatens to cripple humanitarian operations in the war-torn country.
The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.
While Tesla's Fremont facility will produce the upcoming Optimus 3, CEO Elon Musk reveals that the subsequent, higher-volume Optimus 4 generation will be manufactured at Gigafactory Texas, marking a strategic pivot in the company's automation roadmap.
IonQ's acquisition of semiconductor foundry SkyWater Technology marks a pivotal shift, granting it a unique edge in chip manufacturing and positioning it as a frontrunner for lucrative government contracts in the nascent quantum computing race.
